KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cardinal Health (CAH) Shares Outstanding (Diluted Average) (2016 - 2025)

Cardinal Health's Shares Outstanding (Diluted Average) history spans 17 years, with the latest figure at $237.0 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) fell 2.47% year-over-year to $237.0 million; the TTM value through Dec 2025 reached $237.0 million, down 2.47%, while the annual FY2025 figure was $242.0 million, 2.02% down from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $237.0 million at Cardinal Health, down from $239.0 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $294.0 million in Q1 2021 and bottomed at $237.0 million in Q4 2025.
  • The 5-year median for Shares Outstanding (Diluted Average) is $255.5 million (2023), against an average of $261.2 million.
  • The largest annual shift saw Shares Outstanding (Diluted Average) rose 0.34% in 2021 before it dropped 8.79% in 2023.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $281.0 million in 2021, then dropped by 5.34% to $266.0 million in 2022, then fell by 6.77% to $248.0 million in 2023, then fell by 2.02% to $243.0 million in 2024, then fell by 2.47% to $237.0 million in 2025.
  • Per Business Quant, the three most recent readings for CAH's Shares Outstanding (Diluted Average) are $237.0 million (Q4 2025), $239.0 million (Q3 2025), and $242.0 million (Q2 2025).